ArticleAnti-cancer drugs2020

Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.

Chang-Cheng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.